Evidence map›Paper›PMID 27332624›Full record

ArticleArthritis & rheumatology (Hoboken, N.J.)2016

Epigenetic Signatures of Salivary Gland Inflammation in Sjögren's Syndrome.

Michael B Cole, Hong Quach, Diana Quach, Alice Baker, Kimberly E Taylor, Lisa F Barcellos, Lindsey A Criswell

Open access · hybridAbstract read
In one paragraph

Article in Arthritis & rheumatology (Hoboken, N.J.), 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 39 papers.

0numbers the graph read from it
0cells of the map it votes in
39citing papers in PubMed
6.2field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

39 citing papers in PubMed, 68 citations in OpenAlex.

  1. Trial
  2. Review
  3. Article
  4. Review
  5. Review
  6. Article
  7. Review
  8. Article
  9. IFN-γ-producing TScience translational medicine · 2024
    Article
  10. Article
  11. Article
  12. Article
  13. Review
  14. Review
  15. Article
  16. Article
  17. Review
  18. Article
  19. Sjögren's syndrome: a systemic autoimmune disease.Clinical and experimental medicine · 2022
    Review
  20. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 1 country.

Michael B ColeUniversity of California, Berkeley.
Hong QuachUniversity of California, Berkeley.
Diana QuachUniversity of California, Berkeley.
Alice BakerUniversity of California, Berkeley.
Kimberly E TaylorRussell/Engleman Rheumatology Research Center, University of California, San Francisco.
Lisa F BarcellosUniversity of California, Berkeley.
Lindsey A CriswellRussell/Engleman Rheumatology Research Center, University of California, San Francisco.
University of California, Berkeley · USUniversity of California, San Francisco · US

Funding

Genetic and epigenetic contributions to Sjogren's syndromeR03DE024316 · NIDCR · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI CRISWELL, LINDSEY ANN · 2015 to 2016
$474k
Signals of Epigenetic Modification in Sjogrens SyndromeF31DE025176 · NIDCR · UNIVERSITY OF CALIFORNIA BERKELEY · PI COLE, MICHAEL · 2015 to 2018
$139k
INTERNATIONAL RESEARCH REGISTRY NETWORK FOR SJOGERNS SYNDROME-268032636N01DE032636 · NIDCR · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI GREENSPAN, JOHN · 2005 to 2006
–
NHLBI NIH HHS HHSN268201300057CNIDCR NIH HHS F31 DE025176NIDCR NIH HHS N01 DE032636NIDCR NIH HHS R03 DE024316
6 · The paper itself

Abstract

objectiveSjögren's syndrome (SS) is a complex multisystem autoimmune disease that results in progressive destruction of the exocrine glands. The purpose of this study was to characterize epigenetic changes in affected gland tissue and describe the relationship of these changes to known inflammatory processes.

methodsA genome-wide DNA methylation study was performed on human labial salivary gland (LSG) biopsy samples obtained from 28 female members of the Sjögren's International Collaborative Clinical Alliance (SICCA) Registry. Gland tissue was methylotyped using the Illumina HumanMethylation450 BeadChip platform, followed by rigorous probe-filtering and data-normalization procedures.

resultsA genome-wide case-control study of 26 of the 28 subjects revealed 7,820 differentially methylated positions (DMPs) associated with disease status, including 5,699 hypomethylated and 2,121 hypermethylated DMPs. Further analysis identified 57 genes that were enriched for DMPs in their respective promoters; many are involved in immune response, including 2 previously established SS genetic risk loci. Bioinformatics analysis highlighted an extended region of hypomethylation surrounding PSMB8 and TAP1, consistent with an increased frequency of antigen-presenting cells in LSG tissue from the SS cases. Transcription factor motif enrichment analysis revealed the specific nature of the genome-wide methylation differences, demonstrating colocalization of SS-associated DMPs with stress- and immune response-related motifs.

conclusionOur findings underscore the utility of CpG methylotyping as an independent probe of active disease processes in SS, offering unique insights into the composition of disease-relevant tissue. Methylation profiling implicated several genes and pathways previously thought to be involved in disease-related processes, as well as a number of new candidates.

Indexed as

AdultAgedAntigen-Presenting CellsATP Binding Cassette Transporter, Subfamily B, Member 2Case-Control StudiesCathepsin ZDNA MethylationEpigenesis, GeneticFemaleGenotypeHumansIntracellular Signaling Peptides and ProteinsMembrane ProteinsMicroRNAsMiddle AgedPrincipal Component AnalysisATP Binding Cassette Transporter, Subfamily B, Member 2Cathepsin ZCTSZ protein, humanIntracellular Signaling Peptides and ProteinsLMP7 proteinMembrane ProteinsMicroRNAsMIRN339 microRNA, humanProteasome Endopeptidase ComplexPTPRCAP protein, humanTAP1 protein, humanTNFRSF13B protein, humanTransmembrane Activator and CAML Interactor Protein

Identifiers

PMID27332624
PMCPMC5132022
OpenAlexW2467335009

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.